Explore Our Biomarker Menu

Biomarker:

IL-12-p70

Biological or Clinical Significance:

Interleukin-12 p70 (IL-12p70) heterodimer, composed of p35 and p40 subunits, is a major Th1-driving cytokine, promoting cell-mediated immunity. Inability of TNFa/PGE2 to induce IL-12p70 strongly enhances the lipopolysaccharide (LPS)–induced IL-12p70 production. In addition to the selective induction of IL-12p40 in TNFa-stimulated DCs, PGE2 inhibits the production of IL-12p70 in DCs stimulated with LPS or CD40 ligand. Suppression of bioactive IL-12p70 may have negative impact on anticancer
vaccination with PGE2-matured DCs.

References:

Analyte:

IL-12-p70

Matrix:

Human Serum

Status:

Offered

Sensitivity-LLOQ:

0.460 pg/mL

Sensitivity-ULOQ:

platform

Ella

Required Sample Volume

null

Disease State:

null

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.